Every year, nearly 70 million people worldwide suffer a traumatic brain injury (TBI) from car crashes, sports accidents, combat, or falls. Even after the visible wounds heal, a hidden process called epileptogenesis can slowly transform injured brain tissue into a seizure-prone state. Months or even years later, the first seizure strikes — and once post-traumatic epilepsy (PTE) develops, it is usually a lifelong condition.
For the past 50 years, medicine's approach has been the same: wait for the first seizure, then treat the symptoms. Dr. Samba Reddy, a distinguished professor of neuroscience at Texas A&M, and his team have now demonstrated a radically different strategy.
The therapy. The key molecule is sodium butyrate, a short-chain fatty acid produced naturally when gut bacteria ferment dietary fiber. In a study published in Experimental Neurology, the team treated animals with sodium butyrate during the critical window after brain injury but before epilepsy took hold. The results were striking: the therapy reduced brain inflammation, protected vulnerable neurons, improved memory and mood, and made seizures significantly harder to trigger and far less frequent.
How it works. Sodium butyrate acts as an epigenetic modulator — it inhibits histone deacetylases (HDACs), enzymes that normally tighten DNA packaging and silence genes. By relaxing DNA, sodium butyrate re-activates protective genes that calm inflammation and promote neural repair. In essence, it rewrites the brain's response to injury at the molecular level, steering it away from the path toward epilepsy.
Broader implications. Because chronic inflammation and epigenetic changes drive damage in many diseases, the therapy may have applications far beyond epilepsy. The same sodium butyrate mechanism could help in spinal cord injuries, Alzheimer's disease, anxiety, and depression — wherever inflammation disrupts healthy brain function. "Intervening upstream rather than downstream, at the molecular level, by targeting pathways that drive inflammation," Reddy explains, is a principle that could apply across a spectrum of neurological conditions.